Homo sapiens Protein: DYNC1H1 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-20704.6 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | DYNC1H1 | ||||||||||||||||||||||
Protein Name | dynein, cytoplasmic 1, heavy chain 1 | ||||||||||||||||||||||
Synonyms | DHC1; DHC1a; DNCH1; Dnchc1; DNCL; DNECL; DYHC; HL-3; p22; SMALED1; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000348965 | ||||||||||||||||||||||
InnateDB Gene | IDBG-20700 (DYNC1H1) | ||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. | ||||||||||||||||||||||
Subcellular Localization | Cytoplasm, cytoskeleton. | ||||||||||||||||||||||
Disease Associations | Charcot-Marie-Tooth disease 2O (CMT2O) [MIM:614228]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced. {ECO:0000269PubMed:21820100}. Note=The disease is caused by mutations affecting the gene represented in this entry.Mental retardation, autosomal dominant 13 (MRD13) [MIM:614563]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD13 is associated with variable neuronal migration defects and mild dysmorphic features. Some patients may also show signs of peripheral neuropathy, such as abnormal gait and hyporeflexia. {ECO:0000269PubMed:21076407, ECO:0000269PubMed:22368300, ECO:0000269PubMed:23033978, ECO:0000269PubMed:23603762}. Note=The disease is caused by mutations affecting the gene represented in this entry.Spinal muscular atrophy, lower extremity-predominant 1, autosomal dominant (SMALED1) [MIM:158600]: A form of spinal muscular atrophy, a neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. SMALED1 is characterized by muscle weakness predominantly affecting the proximal lower extremities. {ECO:0000269PubMed:22459677, ECO:0000269PubMed:22847149}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 126 experimentally validated interaction(s) in this database.
They are also associated with 11 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR003593
AAA+ ATPase domain IPR004273 Dynein heavy chain domain IPR010987 Glutathione S-transferase, C-terminal-like IPR011704 ATPase, dynein-related, AAA domain IPR012336 Thioredoxin-like fold IPR013594 Dynein heavy chain, domain-1 IPR013602 Dynein heavy chain, domain-2 IPR027417 P-loop containing nucleoside triphosphate hydrolase |
||||||||||||||||||||||
PFAM |
PF03028
PF07728 PF13098 PF13192 PF13462 PF13905 PF08385 PF08393 |
||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART |
SM00382
|
||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | Q14204 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q14204 | ||||||||||||||||||||||
TrEMBL | Q92862 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 1778 | ||||||||||||||||||||||
UniGene | Hs.733153 | ||||||||||||||||||||||
RefSeq | NP_001367 | ||||||||||||||||||||||
HUGO | HGNC:2961 | ||||||||||||||||||||||
OMIM | 600112 | ||||||||||||||||||||||
CCDS | CCDS9966 | ||||||||||||||||||||||
HPRD | 02524 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AB002323 AB290157 AK299878 AY682080 BC021297 L23958 U53530 U61737 | ||||||||||||||||||||||
GenPept | AAA16065 AAB09727 AAC50701 AAH21297 AAT74625 BAA20783 BAG06711 BAG61728 | ||||||||||||||||||||||